Literature DB >> 7473467

Is it possible to predict the first year extent of pain and disability for patients with rheumatoid arthritis?

A van der Heide1, J W Jacobs, H C Haanen, J W Bijlsma.   

Abstract

OBJECTIVE: To investigate prediction of the extent of suffering during the first year of rheumatoid arthritis (RA) with patient characteristics found to be capable of predicting short term or longterm endpoint disability.
METHODS: Ninety-five patients with recently diagnosed RA, participating in a prospective clinical trial, were seen every 3 mo during 1 year. The 12 month and cumulative values of disability (Dutch version of the Health Assessment Questionnaire) and pain (visual analog scale) were related to demographic, clinical, laboratory, and psychological mood variables in correlation and regression analyses.
RESULTS: Baseline values of disability and pain were related most strongly to 12 mo and cumulative values of disability; baseline pain was virtually the only important predictor of 12 mo and cumulative pain. Other baseline characteristics had virtually no additional predictive power.
CONCLUSION: The short term disease course of RA in terms of disability and pain is most strongly related to the baseline values of these variables, and cannot reliably be predicted with frequently recognized longterm prognostic factors, such as rheumatoid factor status or sex.

Entities:  

Mesh:

Year:  1995        PMID: 7473467

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

1.  Predictors of functional status in patients with early rheumatoid arthritis.

Authors:  L M Jansen; D van Schaardenburg; I E van Der Horst-Bruinsma; P D Bezemer; B A Dijkmans
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

2.  Polymorphisms of interleukin-31 are associated with anti-CCP levels in females with rheumatoid arthritis.

Authors:  Ji-In Yu; Young-Ran Park; Shin-Seok Lee; Soo-Cheon Chae
Journal:  J Genet       Date:  2014-12       Impact factor: 1.166

3.  Transdermal fentanyl for the treatment of pain caused by rheumatoid arthritis.

Authors:  Gabriel Herrero-Beaumont; Olav Bjorneboe; Ute Richarz
Journal:  Rheumatol Int       Date:  2004-10-05       Impact factor: 2.631

4.  Association of TBX21 polymorphisms in a Korean population with rheumatoid arthritis.

Authors:  Soo Cheon Chae; Seung Cheol Shim; Hun Taeg Chung
Journal:  Exp Mol Med       Date:  2009-01-31       Impact factor: 8.718

5.  Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth" strategy.

Authors:  T Möttönen; L Paimela; M Leirisalo-Repo; H Kautiainen; J Ilonen; P Hannonen
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

Review 6.  Sociodemographic differences in quality of life in rheumatoid arthritis.

Authors:  Erik J Groessl; Theodore G Ganiats; Andrew J Sarkin
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

7.  Correlation of the score for subjective pain with physical disability, clinical and radiographic scores in recent onset rheumatoid arthritis.

Authors:  Piercarlo Sarzi-Puttini; Tania Fiorini; Benedetta Panni; Maurizio Turiel; Marco Cazzola; Fabiola Atzeni
Journal:  BMC Musculoskelet Disord       Date:  2002-07-19       Impact factor: 2.362

8.  Predicting pain among female survivors of recent interpersonal violence: A proof-of-concept machine-learning approach.

Authors:  Edward Lannon; Francisco Sanchez-Saez; Brooklynn Bailey; Natalie Hellman; Kerry Kinney; Amber Williams; Subodh Nag; Matthew E Kutcher; Burel R Goodin; Uma Rao; Matthew C Morris
Journal:  PLoS One       Date:  2021-07-29       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.